Results 201 to 210 of about 1,198,510 (287)

Synthesis and characterization of chitosan-functionalized nanostructured lipid carriers with temozolomide: cytotoxic effects and chromosomal instability in human glioblastoma cells. [PDF]

open access: yesNaunyn Schmiedebergs Arch Pharmacol
Negreiros HA   +21 more
europepmc   +1 more source

Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT The global burden of multidrug‐resistant tuberculosis (MDR‐TB) and the rising incidence of nontuberculous mycobacterial (NTM) infections highlight the urgent need for innovative therapeutic strategies. Current treatments are prolonged, toxic, and increasingly compromised by resistance and limited diagnostic capacity.
Tânia Silva   +23 more
wiley   +1 more source

Engineering Optimized Nanostructured Lipid Carriers for Astaxanthin: A Response Surface Methodology Approach. [PDF]

open access: yesInt J Nanomedicine
Abdol Wahab NR   +4 more
europepmc   +1 more source

AI‐Driven Rational Design of Nanotherapeutics for Pancreatic Ductal Adenocarcinoma

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) remains a formidable malignancy characterized by late diagnosis, high recurrence rates, and pronounced chemoresistance. While nanoparticle‐based drug delivery systems (NDDS) offer theoretical advantages over conventional therapies, their clinical translation in PDAC has been severely limited.
Seohyun Choo   +4 more
wiley   +1 more source

Enhanced encapsulation and membrane retention of <i>Teleogryllus mitratus</i> protein via hydrophobic ion-pairing in nanostructured lipid carriers. [PDF]

open access: yesInt J Pharm X
Inthorn J   +7 more
europepmc   +1 more source

Aptamer–Based Targeted Protein Degradation: Mechanistic Principles, Delivery Strategies, and Translational Opportunities

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Targeted elimination of pathogenic proteins remains a fundamental challenge in therapeutic intervention, particularly for proteins considered “undruggable” by conventional inhibition‐based approaches. Aptamer–based targeted protein degradation (TPD) has emerged as a versatile strategy that leverages the high specificity, structural ...
Ambrin Malik   +3 more
wiley   +1 more source

Smart Carbon Dot Nanomaterials: Emerging Structure, Properties, and Biomedical Insights—A Comprehensive Review

open access: yesMetalMat, EarlyView.
This review presents recent advances in smart carbon dot (CD) nanomaterials, emphasizing their synthesis, structural design, fluorescence mechanisms, and biomedical applications. CDs, typically below 10 nm, exhibit tunable photoluminescence, excellent stability, and biocompatibility.
Trisita Ghosh   +2 more
wiley   +1 more source

Applications of nanocarrier‐delivered RNA interference in agricultural biological control (2009–2025)

open access: yesNew Plant Protection, EarlyView.
Despite 17 years of development, the effectiveness of nanocarrier‐delivered RNAi pesticide (NDRP) for agricultural biological control remains limited. The successful development of effective NDRP development requires the coordinated optimization of target gene selection and nanocarrier properties, including RNA dosage, multi‐gene targeting, protection ...
Shi Dong Wang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy